Cembra Money Bank AG:企業の戦略・SWOT・財務情報

◆英語タイトル:Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11818
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cembra Money Bank AG – Strategy, SWOT and Corporate Finance Report
Summary

Cembra Money Bank AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cembra Money Bank AG (Cembra Money Bank) is a consumer finance company. It offers a range of personal loans, auto leases and loans, credit cards, insurance, and deposit and savings products. The bank offers cash loans, and financing for used vehicles. It provides a range of credit cards in partnership with Migros, Fnac, TCS, and Conforama, among others. The bank offers insurance products such as payment protection insurance, payment protection insurance plus, and payment protection insurance for single-member companies. It operates through a network of branches; and alternative distribution channels, including independent agents, the internet, auto dealers, and credit card partners. Cembra Money Bank is headquartered in Zurich, Switzerland.

Scope

- Detailed information on Cembra Money Bank AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cembra Money Bank AG in the form of a SWOT analysis
- An in-depth view of the business model of Cembra Money Bank AG including a breakdown and examination of key business segments
- Intelligence on Cembra Money Bank AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cembra Money Bank AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cembra Money Bank AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cembra Money Bank AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cembra Money Bank AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Cembra Money Bank AG: Company Overview 9
Cembra Money Bank AG: Overview and Key Facts 9
Cembra Money Bank AG: Overview 9
Cembra Money Bank AG: Key Facts 9
Cembra Money Bank AG: Key Employees 10
Cembra Money Bank AG: Key Employee Biographies 11
Cembra Money Bank AG: Major Products and Services 12
Cembra Money Bank AG: Company History 13
Cembra Money Bank AG: Management Statement 15
Cembra Money Bank AG: Locations and Subsidiaries 18
Cembra Money Bank AG: Key Competitors 19
Cembra Money Bank AG: Company Analysis 20
Cembra Money Bank AG: Business Description 20
Cembra Money Bank AG: SWOT Analysis 21
Cembra Money Bank AG: SWOT Overview 21
Cembra Money Bank AG: Strengths 21
Cembra Money Bank AG: Weaknesses 22
Cembra Money Bank AG: Opportunities 22
Cembra Money Bank AG: Threats 23
Cembra Money Bank AG: Corporate Financial Deals Activity 24
Cembra Money Bank AG: Financial Deals Overview 24
Cembra Money Bank AG: Targets and Partners 26
Cembra Money Bank AG: Top Deals 2014 – 2018YTD* 27
Cembra Money Bank AG: Mergers and Acquisitions 28
Cembra Money Bank AG: Capital Raising 29
Cembra Money Bank AG: Recent Developments 30
Cembra Money Bank AG: News and Events Summary 30
Cembra Money Bank AG: Corporate Governance 31
Cembra Money Bank AG: Financial Deals 31
Cembra Money Bank AG: Financial Performance 31
Appendix 33
Contact Us 33
Methodology 33
About MarketLine 34

List of Tables
Table 1: Cembra Money Bank AG: Key Facts
Table 2: Cembra Money Bank AG: Key Employees
Table 3: Cembra Money Bank AG: Company History
Table 4: Cembra Money Bank AG: Locations and Subsidiaries
Table 5: Cembra Money Bank AG: Key Competitors
Table 6: Cembra Money Bank AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Cembra Money Bank AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Cembra Money Bank AG: M&A Average Deal Size - Value (US$m)
Table 9: Cembra Money Bank AG: Targets and Partners
Table 10: Cembra Money Bank AG: Top Deals 2014 - 2018YTD*
Table 11: Cembra Money Bank AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Cembra Money Bank AG: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Cembra Money Bank AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Cembra Money Bank AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Cembra Money Bank AG: News and Events Summary
Table 16: Cembra Money Bank AG: Corporate Governance
Table 17: Cembra Money Bank AG: Financial Deals
Table 18: Cembra Money Bank AG: Financial Performance

List of Figures
Figure 1: Cembra Money Bank AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Cembra Money Bank AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Cembra Money Bank AG: M&A Average Deal Size - Value (US$m)
Figure 4: Cembra Money Bank AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Cembra Money Bank AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Cembra Money Bank AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Cembra Money Bank AG: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Cembra Money Bank AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NeuroSearch AS (NEUR)-製薬・医療分野:企業M&A・提携分析
    Summary NeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patien …
  • OncoTartis Inc-製薬・医療分野:企業M&A・提携分析
    Summary OncoTartis Inc (OncoTartis) is a biotechnology company with a focus on development of various treatments for various types of cancers. Its lead candidate OT-82, an orally available NicotinAMide Phosphoribosyl Transferase inhibitor, is being developed for treating broad range of leukemias and …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ecobank Transnational Inc:企業の戦略・SWOT・財務情報
    Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report Summary Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • Independent News & Media Plc:企業の戦略的SWOT分析
    Independent News & Media Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析
    U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Double Bond Pharmaceutical International AB (DBPB):製薬・医療:M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • Bunzl plc (BNZL)-医療機器分野:企業M&A・提携分析
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company that supplies a broad range of non-food products to a diverse market sectors. The company offers an array of food packaging, disposable tableware and catering equipment, cleaning and hygiene supplies, guest amenities, persona …
  • Bassett Furniture Industries, Incorporated (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries, Incorporated (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Cochlear Ltd (COH):企業の製品パイプライン分析
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • China Construction Bank Corp:企業の戦略・SWOT・財務分析
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Gildan Activewear Inc.:企業の戦略・SWOT・財務情報
    Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report Summary Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆